Skip to main content
Caplight Logo









Phiogen

Phiogen

Private
Houston, TexasHealthcare & Life Scienceshttps://phiogen.com/

Last Round

Grant

Aug 26, 2025

Total Funding Raised

$1.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Phiogen is a biotechnology company that develops a platform to generate next-generation therapeutics utilizing bacteriophages for broad patient applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

bacteriophage therapeuticsphage therapyantimicrobial resistanceAMRdrug-resistant infectionssuperbugsphage discovery platformoff-the-shelf therapeuticsantibiotic alternativespreclinical biotechnologyrecurrent urinary tract infectionsrUTIsdirected evolutionbloodstream infectionsbacteremiadrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phiogen Comparables

Compare Phiogen with similar companies based on industry and business-model similarity.

Phiogen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
B-Phage
84%
Locus Biosciences
83%
PhageOne
82%

Phiogen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 26, 2025
AcceleratorSep 11, 2024
SeedJan 1, 2023
AcceleratorJan 28, 2022

Phiogen Investors

Notable investors and investment history

Phiogen investors
InvestorRounds
CARB-XGrant
INCATEAccelerator
Springboard EnterprisesAccelerator
BCM VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors grew 763% MoM to 14.1K.

  • May 19, 2026

    Monthly visitors grew 168% MoM.

Phiogen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Phiogen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phiogen's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Year Founded2023
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?